Drug profile · INN
topotecan hydrochloride
TOPOTECAN HYDROCHLORIDE
topotecan hydrochloride (TOPOTECAN HYDROCHLORIDE) is a dna topoisomerase i, mitochondrial inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — topotecan hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 20
- Data quality
- 0.84
Quick answer
topotecan hydrochloride (TOPOTECAN HYDROCHLORIDE) is a dna topoisomerase i, mitochondrial inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA topoisomerase I, mitochondrial inhibitor
Primary target: DNA topoisomerase 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is topotecan hydrochloride?
topotecan hydrochloride (TOPOTECAN HYDROCHLORIDE) is a dna topoisomerase i, mitochondrial inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for topotecan hydrochloride?
TOPOTECAN HYDROCHLORIDE is a marketed brand name for topotecan hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of topotecan hydrochloride?
topotecan hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.